Evidence map›Paper›PMID 27586005›Full record

ArticleAnnals of surgical oncology2016

Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging Laparoscopy.

Robert J S Coelen, Anthony T Ruys, Jimme K Wiggers, Chung Y Nio, Joanne Verheij, Dirk J Gouma, Marc G H Besselink, Olivier R C Busch, Thomas M van Gulik

Open access · hybridAbstract read
In one paragraph

Article in Annals of surgical oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Cholangiocarcinoma 2026: status quo, unmet needs and priorities.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Nationwide treatment and outcomes of perihilar cholangiocarcinoma.Liver international : official journal of the International Association for the Study of the Liver · 2021
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Optimal perioperative care in peri-hilar cholangiocarcinoma resection.European surgery : ACA : Acta chirurgica Austriaca · 2018
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Robert J S CoelenDepartment of Surgery, Academic Medical Center, Amsterdam, The Netherlands. r.j.coelen@amc.nl.
Anthony T RuysDepartment of Surgery, Academic Medical Center, Amsterdam, The Netherlands.
Jimme K WiggersDepartment of Surgery, Academic Medical Center, Amsterdam, The Netherlands.
Chung Y NioDepartment of Radiology, Academic Medical Center, Amsterdam, The Netherlands.
Joanne VerheijDepartment of Pathology, Academic Medical Center, Amsterdam, The Netherlands.
Dirk J GoumaDepartment of Surgery, Academic Medical Center, Amsterdam, The Netherlands.
Marc G H BesselinkDepartment of Surgery, Academic Medical Center, Amsterdam, The Netherlands.
Olivier R C BuschDepartment of Surgery, Academic Medical Center, Amsterdam, The Netherlands.
Thomas M van GulikDepartment of Surgery, Academic Medical Center, Amsterdam, The Netherlands.
Academic Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNearly half of patients with perihilar cholangiocarcinoma (PHC) have incurable tumors at laparotomy. Staging laparoscopy (SL) potentially detects metastases or locally advanced disease, thereby avoiding unnecessary laparotomy. However, the diagnostic yield of SL has decreased with improved imaging in recent years.

objectiveThe aim of this study was to identify predictors for detecting metastasized or locally advanced PHC at SL and to develop a risk score to select patients who may benefit most from this procedure.

methodsData of patients with potentially resectable PHC who underwent SL between 2000 and 2015 in our center were retrospectively analyzed. Multivariable logistic regression analysis was used to identify independent predictors and to develop a preoperative risk score.

resultsUnresectable PHC was detected in 41 of 273 patients undergoing SL (yield 15 %). Overall sensitivity of SL was 30 %, with highest sensitivity for detecting peritoneal metastases (73 %). Preoperative imaging factors that were independently associated with unresectability at SL were tumor size ≥4.5 cm, bilateral portal vein involvement, suspected lymph node metastases, and suspected (extra)hepatic metastases on imaging without the possibility of diagnosis by percutaneous- or endoscopic ultrasound-guided biopsy. The derived preoperative risk score showed good discrimination to predict unresectability (area under the curve 0.77, 95 % confidence interval 0.68-0.86) and identified three subgroups with a predicted low-risk of 7 % (N = 203 patients), intermediate-risk of 21 % (N = 39), and high-risk of 58 % (N = 31).

conclusionsA selective approach for SL in PHC is recommended since the overall yield is low. The proposed preoperative risk score is useful in selecting patients for SL.

Indexed as

AgedBile Duct NeoplasmsCholangiocarcinomaContraindications, ProcedureHumansLaparoscopyLiver NeoplasmsLymphatic MetastasisMiddle AgedNeoplasm StagingPeritoneal NeoplasmsPortal VeinPredictive Value of TestsRisk AssessmentTumor Burden

Identifiers

PMID27586005
PMCPMC5149561
OpenAlexW2511737210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.